The turf war between the pharmaceutical industry and Drug Controller General of India (DCGI) is set to intensify after sources close to DCGI confirmed on Monday that the drug controller will soon be approaching the Supreme Court over the issue of centralising power to grant Certificate of Pharmaceutical Products (CoPP)